Compound Detail
CHEMBL29404
ENECADIN 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL29404 |
| Name | ENECADIN |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | SZSHJTJCJOWMHM-UHFFFAOYSA-N |
1
Targets
2
Activities
1
Assay Types
0
PK Parameters
3
Publications
3
Known Names
1
Indications
Molecular Properties
357.5
MW (Da)
4.63
ALogP
4
HBA
0
HBD
38.2
PSA (Ų)
0.65
QED
0
Ro5 Violations
8
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Indications
Stroke
Activity Summary
IC50 2 meas. best 6.0
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Unchecked CHEMBL612545 | IC50 | 6.0 | 5.555 | 1000.0 | 2 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Unchecked | IC50 | = | 1000.0 | nM | 6.0 | Inhibition of [3H]-BTX binding to cardiac voltage-gated sodium channel | 11170622 |
| Unchecked | IC50 | = | 7700.0 | nM | 5.11 | Inhibition of veratridine-induced guanidine flux in cardiac voltage-gated sodium... | 11170622 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 4 |
| 11170622 | 10.1021/jm000155h | Unchecked | 2 |
| 11170622 | 10.1021/jm000155h | Rattus norvegicus | 1 |
Data from ChEMBL 36 via Core Engine